Company
GLX Analytix
Unlocking novel biomarkers to transform patient outcomes
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- pharmaceutical partnerships
Claim, correct or request removal
Record updated 18 September 2026
About
Clinical-stage blood test platform for diagnosing and monitoring brain diseases.
Products
- Other
- GLX Signature Platform
Loading relationship preview